Signal transduction in cardiac and vascular tissue from normotensive and transgenic hypertensive TGR(mREN2)27 rats

European Journal of Pharmacology

Volumn 341, Issue 2-3, 1998, Pages 337-341

  Witte, Klaus ^a   Schnecko, Anke ^a   Perbandt, Karsten ^a   Höfer, Stephan ^a   Lemmer, Björn ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Adenylyl cyclase; Aorta; Guanylyl cyclase, soluble; Heart; Hypertension

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANYLATE CYCLASE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; TRANSGENIC ANIMAL; VASCULAR TISSUE;

ADENYLATE CYCLASE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; AORTA, THORACIC; CYCLIC AMP; CYCLIC GMP; GUANYLATE CYCLASE; HEART; HYPERTENSION; MALE; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 0032509747     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01486-6     Document Type: Article

References (21)

1. Ackermann, H., 1997. Biometrische Analyse von Stichproben. 7th ed. Epsilon Verlag, Hochheim, Darmstadt.
2. Arribas S., Sanchez-Ferrer C.F., Peiro C., Ponte A., Salaices M., Marin M. Functional vascular renin-angiotensin system in hypertensive transgenic rats for the mouse renin gene Ren-2. Gen. Pharmac. 25:1994;1163-1170.
3. Bachmann S., Peters J., Engler E., Ganten D., Mullins J. Transgenic rats carrying the mouse renin gene-morphological characterization of a low-renin hypertension model. Kidney Int. 41:1992;24-36.
4. Böhm M., Moll M., Schmid B., Paul M., Ganten D., Castellano M., Erdmann E. β-Adrenergic neuroeffector mechanisms in cardiac hypertrophy of renin transgenic rats. Hypertension. 24:1994;653-662.
5. Castellano M., Böhm M. The cardiac β-adrenoceptor-mediated signaling pathway and its alterations in hypertensive heart disease. Hypertension. 29:1997;715-722.
6. Dominiczak A.F., Bohr D.F. Nitric oxide and its putative role in hypertension. Hypertension. 25:1995;1202-1211.
7. Forte P., Copland M., Smith L.M., Milne E., Sutherland J., Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet. 349:1997;837-842.
8. Konishi M., Su C. Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension. 5:1983;881-886.
9. Lemmer B., Witte K. Circadian rhythm of the in vitro stimulation of adenylate cyclase in rat heart tissue. Eur. J. Pharmacol. 159:1989;311-315.
10. Limbird L.E., Hickey A.R., Lefkowitz R.J. Unique uncoupling of the frog erythrocyte adenylyl cyclase system by manganese ions. J. Biol. Chem. 254:1979;2677-2683.
11. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
12. Lüscher T.F., Vanhoutte P.M. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension. 8:1986;344-348.
13. Lüscher T.F., Diederich D., Weber E., Vanhoutte P.M., Bühler F.R. Endothelium-dependent responses in carotid and renal arteries of normotensive and hypertensive rats. Hypertension. 11:1988;573-578.
14. Mullins J.J., Peters J., Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 renin gene. Nature. 344:1990;541-544.
15. Panza J.A., Garcia C.E., Kilcoyne C.M., Quyyumi A.A., Cannon R.O. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Circulation. 91:1995;1732-1738.
16. Pinto Y.M., Buikema H., van Gilst W.H., Scholtens E., van Geel P.P., de Graeff P.A., Wagner J., Paul M. Cardiovascular end-organ damage in Ren-2 transgenic rats compared to spontaneously hypertensive rats. J. Mol. Med. 75:1997;371-377.
17. Sawada Y., Sakamaki T., Nakamura T., Sato K., Ono Z., Murata K. Release of nitric oxide in response to acetylcholine is unaltered in spontaneously hypertensive rats. J. Hypertens. 12:1994;745-750.
18. Tokita Y., Franco-Saenz R., Reimann E.M., Mulrow P.J. Hypertension in the transgenic rat TGR(mRen-2)27 may be due to enhanced kinetics of the reaction between mouse renin and rat angiotensinogen. Hypertension. 23:1994;422-427.
19. Tschudi M.R., Noll G., Arnet U., Novosel D., Ganten D., Lüscher T.F. Alterations in coronary artery vascular reactivity of hypertensive Ren-2 transgenic rats. Circulation. 89:1994;2780-2786.
20. Villarreal F.J., Mackenna D.A., Omens J.H., Dillmann W.H. Myocardial remodeling in hypertensive Ren-2 transgenic rats. Hypertension. 25:1995;98-104.
21. Witte K., Schnecko A., Zuther P., Lemmer B. Contribution of the nitric oxide-cGMP system to circadian regulation of blood pressure in normotensive Wistar-Kyoto rats. Cardiovasc. Res. 30:1995;682-688.